Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Radioiodine Therapy for Hyperthyroidism
source: The New England Journal of Medicine
year: 2011
authors: Douglas S. Ross
summary/abstract:A 37-year-old woman receives a diagnosis of Graves’ disease and is treated with methimazole for 1 year. After completing this treatment, she presents with recurrent symptoms of hyperthyroidism. Radioiodine ablation is recommended.
organization: Massachusetts General Hospital, USADOI: 10.1056/NEJMct1007101
read more full text
myBinderRelated Content
-
Weight Gain After Treatment of Graves’ Disease in ChildrenObjective: The frequency of and risk fa...
-
Cancer Mortality Following Treatment for Adult HyperthyroidismContext: High-dose iodine 131 is the tr...
-
Treating Graves’ – Different StrokesOnce the diagnosis of hyperthyroidism du...
-
Clinical and Socioeconomic Factors Influence Treatment Decisions in Graves’ DiseaseBackground: Definitive treatment of Gra...
-
Management of Thyroid Eye Disease in the United Kingdom: A Multi-Centre Thyroid Eye Disease AuditThis article aims to provide baseline da...
-
Predictive Score for the Development or Progression of Graves’ Orbitopathy in Patients With Newly Diagnosed Gr...Objective: To construct a predictive sc...
-
Low Iodine Diet Does Not Improve the Efficacy of Radioiodine for the Treatment of Graves’ DiseaseObjective: Consuming a low-iodine diet ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Facebook
Google